Why Partner With Us?
The LAG-3 Targeted Drug Development Summit industry specific focus makes it the main platform for bringing together the decision makers in immune-oncology. This is your opportunity to get the message out about your products and services, elevate your brand and demonstrate your expertise in this growing field. Register your interest for the 2023 program.
Partnership opportunities will enable you to:
Accelerate and support clinical development, whilst positioning yourself as the leading CRO in this space
Share what your PDX, syngeneic and humanized models offer to improve the quality of preclinical research, critical to the timely advancement of these novel therapeutics
Showcase your capabilities to boost the early development of immune-oncology therapies
Display your regulatory expertise to support developers in their efforts